Abstract
Photothermal therapy (PTT) has been pre-clinically used in cancer treatment, but incomplete tumor removal and heat endurance of tumor cells could induce significant tumor relapse. In article number 1902636, Xiaolong Liu, Jingfeng Liu, and co-workers report a programmable antitumor strategy that combines artificially engineered natural killer cells with anti-heat endurance of DNAzyme as a powerful adjuvant for immuno-enhancing the therapeutic efficiency of PTT.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
